earnings
confidence high
sentiment neutral
materiality 0.80
Omnicell Q4 rev $314M (+2% YoY), GAAP net loss $0.05/sh; FY26 revenue guide $1.215-1.255B
OMNICELL, INC.
2025-FY EPS reported
$0.04
revenue$1,184,845,000
- Q4 total revenues $314M (+2% YoY); full-year 2025 rev $1.185B (+7% YoY).
- GAAP net loss Q4 $2M ($0.05 diluted loss) vs net income $16M ($0.34) in Q4 2024.
- Non-GAAP net income Q4 $18M ($0.40) vs $28M ($0.60) YoY; FY25 non-GAAP EPS $1.62.
- FY2025 product bookings $535M (-4% YoY); ARR $635.6M (+9.6%); product backlog $640.3M.
- Launched Titan XT dispensing system at ASHP Midyear; guides FY26 rev $1.215-1.255B, Non-GAAP EBITDA $145-160M.